0001104659-24-060003.txt : 20240510
0001104659-24-060003.hdr.sgml : 20240510
20240510172329
ACCESSION NUMBER: 0001104659-24-060003
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240508
FILED AS OF DATE: 20240510
DATE AS OF CHANGE: 20240510
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Papandreou George
CENTRAL INDEX KEY: 0001995296
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39421
FILM NUMBER: 24936102
MAIL ADDRESS:
STREET 1: C/O ORCHESTRA BIOMED HOLDINGS, INC.
STREET 2: 150 UNION SQUARE DRIVE
CITY: NEW HOPE
STATE: PA
ZIP: 18938
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Orchestra BioMed Holdings, Inc.
CENTRAL INDEX KEY: 0001814114
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 150 UNION SQUARE DRIVE
CITY: NEW HOPE
STATE: PA
ZIP: 18938
BUSINESS PHONE: 646-343-9298
MAIL ADDRESS:
STREET 1: 150 UNION SQUARE DRIVE
CITY: NEW HOPE
STATE: PA
ZIP: 18938
FORMER COMPANY:
FORMER CONFORMED NAME: Health Sciences Acquisitions Corp 2
DATE OF NAME CHANGE: 20200603
4
1
tm2414108-5_4seq1.xml
OWNERSHIP DOCUMENT
X0508
4
2024-05-08
0
0001814114
Orchestra BioMed Holdings, Inc.
OBIO
0001995296
Papandreou George
C/O ORCHESTRA BIOMED HOLDINGS, INC.
150 UNION SQUARE DRIVE
NEW HOPE
PA
18938
0
1
0
0
See Remarks
0
Common Stock, par value $0.0001 per share ("Common Stock")
2024-05-08
4
A
0
22000
0
A
42000
D
Stock Option (Right to Buy)
4.98
2024-05-08
4
A
0
33000
0
A
2034-05-08
Common Stock
33000
33000
D
Represents an award of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Common Stock. The RSUs vest as follows: (i) 3,300 RSUs will vest on May 22, 2025, and (ii) the remaining 18,700 RSUs will vest in equal installments on August 22, 2025, November 22, 2025, December 24, 2025, May 22, 2026, August 22, 2026, November 22, 2026, March 25, 2027, May 22, 2027, August 22, 2027, November 22, 2027, March 25, 2028 and May 22, 2028, subject to the Reporting Person's continuous service through such dates.
The stock options will vest as follows: (i) 8,250 of the stock options will vest on May 8, 2025 (the "Vesting Date") and (ii) the remaining 24,750 of the stock options will vest in equal installments every three months on the same day of the month as the Vesting Date, starting on August 8, 2025, subject to the Reporting Person's continuous service through such dates.
General Manager and Senior Vice President, Focal Therapies
/s/ Matthew R. Schob, Attorney-in-Fact
2024-05-10